GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Long-Term Debt

Willow Biosciences (Willow Biosciences) Long-Term Debt : $0.44 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Willow Biosciences Long-Term Debt?

Willow Biosciences's Long-Term Debt for the quarter that ended in Dec. 2023 was $0.44 Mil.

Willow Biosciences's quarterly Long-Term Debt stayed the same from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.00 Mil) but then increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.44 Mil).

Willow Biosciences's annual Long-Term Debt stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.44 Mil).

Willow Biosciences Long-Term Debt Historical Data

The historical data trend for Willow Biosciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Long-Term Debt Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.44

Willow Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.44

Willow Biosciences  (OTCPK:CANSF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Willow Biosciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences (Willow Biosciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Long-Term Debt
Comparable Companies
TSX:VPH TSXV:HASH TSXV:DHB XCNQ:XTRX XCNQ:RVV NEOE:FH XCNQ:IMCC TSXV:MPH TSXV:CANB TSXV:NDVA ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
3D7:Germany WLLW:Canada
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Website
https://www.willowbio.com
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.